I am trying to reconcile the many good and considered posts positing that Akida IP may be in Valeos SCALA 3 or some of the 2024 Mercedes models (out later this year) with the understandably limited information from our company regarding commercially sensitive business dealings and indeed license agreements.
Unless valeo or Mercedes have taken one of the two licenses through megachips or are relying on the 2 node renesas licence then I cannot help but think it highly unlikely that these companies would announce upcoming products to the market, take orders for those products and move to produce those products without the contractual wherewithal in place to guarantee the terms of the relationship with all suppliers.
It may well be that the original EAP agreements or for instance the terms of the partnership agreement with Valeo ( some of which were announced at the time of the partnership announcement) were adequate to cover all future eventualities but I think this seems unlikely. I know that Dio has suggested that with respect to valeo this may well be the case (and I do regard his posts/views highly) but I must admit I am less confident. The reference to milestone payments and the like is certainly reassuring but this seems more aligned to the product development phase than the production phase. It doesn’t mean of course that the agreement doesn’t contain licence fee or production terms clauses but there is not as far as I can see any reference to them.
My understanding of the relevant ASX listing requirements is that certain commercially sensitive licence agreements need not be announced to the market and this may provide an out for our company. however, we would in this case still expect an upfront revenue kicker to show up in the accounts which I do not believe it has done as yet.
Whilst it appears highly highly likely that our working relationship with valeo and merc continue I am hoping that our inclusion in their future products is imminent and not too many iterations away.
I look forward to anyone’s thoughts that may help me to achieve some clarity on this issue.
Cheers.
Good points ...
With reference to Valeo, a "Joint Development " agreement can have numerous commercial iterations. There was agreement with Valeo that would cover some of BrainChips development costs, but no insight to what the commercial outcome of a successful "development using Akida" would be like.
From articles in 2020
Tech developer BrainChip (BRN) has signed a joint development agreement with European automotive supplier Valeo for its Akida system.
Valeo supplies sensors and systems for autonomous vehicles (AV) and advanced driver assistance systems (ADAS).
The tier-one auto supplier will incorporate BrainChip’s Akida neuromorphic System-on-Chip (SoC) as a neural network processor in Valeo’s sensing system.
The SoC will be developed to process data and learn in a way that is a lot more focused and streamlined than previous system architectures.
The low-power, reliable system will bypass the need for an exterior processing unit to integrate large amounts of sensor data, and instead provide a potentially better and more elastic solution in one compact package.
Most likely commercial outcome, IMHO, is a royalty from sales.
Something like 1% - 2%
And this would only become " worthy of ASX announcement" on sales being achieved. Even though Valeo have pre-orders etc, what happens if Valeo goes bust, or production fails etc. etc.
So my logic goes, it's been 3.5 years. Valeo scientists were lauding Spiking Neural Networks as the future back in 2018, they choose to work with BrainChip, so Valeo have been at it for more than 5 years, nothing has been announced that the joint development has been terminated. Is it SCALA 3 ? Very good chance, but not definite. We could still be "developing"